Masahiro Shimonaga, Head of Development - Japan, Corporate Officer at Amgen

Masahiro Shimonaga

Head of Development - Japan, Corporate Officer at Amgen | Japan

Profile last verified July 2026
Pharmaceuticals Verified Profile Japan GLOBIS University - Graduate School of Management
Verified

Work Email

***@amgen.com

Last verified August 2026

Phone Number

(**) *** *** 155

Japan • Phone

Free account · No credit card · 5 profiles/month

Masahiro Shimonaga Socials
Masahiro Shimonaga Work Experience

Head of Development - Japan, Corporate Officer at Amgen in September 2022 - Present

Head of Regulatory Affairs - Japan, Corporate officer at Amgen in September 2021 - September 2022

Medical Director, Development TA Oncology, Medical Development, R&D at Amgen in May 2020 - September 2021

See more See less

Group Manager, Development Regulatory, Regulatory Affairs - Japan at Amgen in October 2016 - April 2020

Manager, Development Regulatory, Regulatory Affairs - Japan at Amgen in May 2013 - September 2016

Regulatory affaires expert at Merck Group in November 2010 - April 2013

Regulatory Function Lead, Regulatory affairs, R&D at AstraZeneca in January 2007 - October 2010

Clinical Research Associate Leader, Clinical Operations, R&D at AstraZeneca in January 2004 - December 2006

Clinical Research Associate, Clinical Operations, R&D at AstraZeneca in April 2002 - December 2003

Masahiro Shimonaga Education

GLOBIS University - Graduate School of Management, 経営学修士(専門職), August 2026

Tohoku University, 博士(工学), August 1993 to August 2026

Masahiro Shimonaga Skills
人材マネジメント 事業戦略 臨床開発 組織開発 Regulatory Filings
About Masahiro Shimonaga’s Current Company
Amgen

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

Discover more about Amgen
Masahiro Shimonaga’s Colleagues
Anam Brennan

Anam Brennan

Boston, Massachusetts, United States

Honors Biochemistry Student at Northeastern University

Process Chemist Co-op on Drug Substance Technologies Synthetics Team at Amgen
(January 2026 – Present)

Christian Robles

Christian Robles

Mexico City, Mexico

Socio Estratégico de Salud-Gobierno | Cedula A1, Competencias directivas

Senior Biopharmaceutical Representative at Amgen
(February 2025 – Present)

Meiling Liang

Meiling Liang

Thousand Oaks, California, United States

Leading Innovation, Driving Global Health Transformation

Senior Vice President of Research at Amgen
(June 2021 – Present)

Jackie Lesage

Jackie Lesage

Greater Milwaukee

Associate Director, Patient Access Liaison-Rare Disease Business Unit

Associate Director, Patient Access Liaison-Rare Disease Business Unit at Amgen
(October 2023 – Present)

Global Safety Manager at Amgen Kft

Global Safety Manager, Safety Lead, National level Safety Responsible Person, Hungary at Amgen Kft
(March 2012 – Present)

Marloes Oosterhof

Marloes Oosterhof

Sunshine Coast, Queensland, Australia

Medical Science Liaison | PhD

National Medical Science Liaison Oncology at Amgen
(March 2025 – Present)

Search similar profiles
Frequently asked questions about Masahiro Shimonaga

What is Masahiro Shimonaga email address?

Email Masahiro Shimonaga at [email protected]. This email is the most updated Masahiro Shimonaga's email found in 2026.

How to contact Masahiro Shimonaga?

To contact Masahiro Shimonaga send an email to [email protected]. (updated on July 2026)

What company does Masahiro Shimonaga work for?

Masahiro Shimonaga works for Amgen.

What is Masahiro Shimonaga's role at Amgen?

Masahiro Shimonaga is Head of Development - Japan, Corporate Officer

What industry does Masahiro Shimonaga work in?

Masahiro Shimonaga works in the Pharmaceuticals industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free